The serum vitamin D status in adults with diabetic retinopathy: A systematic review and meta-analysis

Vitamin D Status in Diabetic Retinopathy: A Meta-Analysis

  • Hongyu Wei Graduate School of Hebei University of Chinese Medicine
  • Hao Wang Hebei Eye Hospital
  • Ke Diao Hebei Eye Hospital
  • Xiaoxuan Wang Hebei Eye Hospital
  • Hong Chen Hebei Eye Hospital
  • Congying Wang Hebei Eye Hospital
  • Minglian Zhang Graduate School of Hebei University of Chinese Medicine
DOI: https://doi.org/10.5937/jomb0-60670
Keywords: Diabetic retinopathy, Vitamin d, 25-hydroxyvitamin D3, 1,25-Dihydroxyvitamin D3, Meta-analysis

Abstract


Background: Emerging evidence suggests that vitamin D may play a crucial role in the development of diabetic retinopathy (DR). However, the extent of vitamin D deficiency in individuals with DR remains uncertain. This study aimed to evaluate serum vitamin D levels in adults with DR.

Methods: A comprehensive literature search was conducted using the Embase, PubMed, and Cochrane databases to identify observational studies assessing serum levels of 25(OH)D₃, 1,25(OH)₂D₃, or total 25(OH)D in individuals with DR. A total of 31 independent studies involving 12,227 diabetic individuals were included in the meta-analysis.

Results: The pooled mean concentration of total 25(OH)D among individuals with diabetes was 16.04 ng/mL (95% CI: 15.13–16.96; I² = 98.8%), while the mean serum level of 25(OH)D₃ in those with DR was 10.68 ng/mL (95% CI: 5.94–15.41; I² = 99.5%), both significantly below the normal reference range. The average concentration of 1,25(OH)₂D₃ was 31.14 pg/mL (95% CI: 24.35–37.94; I² = 98.8%).

Conclusions: Individuals with diabetic retinopathy exhibit significantly reduced levels of vitamin D. These findings support the consideration of vitamin D supplementation in DR management. Further large-scale, prospective studies are needed to clarify the causal relationship between vitamin D and DR.

References

1. Wong TY, Cheung CM, Larsen M, Sharma S, Simo R. Diabetic retinopathy. Nat Rev Dis Primers 2016; 2: 16012.
2. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012; 35(3): 556-64.
3. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 2010; 376(9735): 124-36.
4. Holick MF. Vitamin D deficiency. New Engl J Med 2007; 357(3): 266-81.
5. Luo BA, Gao F, Qin LL. The Association between Vitamin D Deficiency and Diabetic Retinopathy in Type 2 Diabetes: A Meta-Analysis of Observational Studies. Nutrients 2017; 9(3):
6. Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 2014; 21(3): 319-29.
7. Zittermann A, Gummert JF. Nonclassical vitamin D action. Nutrients 2010; 2(4): 408-25.
8. Payne JF, Ray R, Watson DG, Delille C, Rimler E, Cleveland J, et al. Vitamin D insufficiency in diabetic retinopathy. Endocr Pract 2012; 18(2): 185-93.
9. Aksoy H, Akcay F, Kurtul N, Baykal O, Avci B. Serum 1,25 dihydroxy vitamin D (1,25(OH)2D3), 25 hydroxy vitamin D (25(OH)D) and parathormone levels in diabetic retinopathy. Clin Biochem 2000; 33(1): 47-51.
10. Bajaj S, Singh RP, Dwivedi NC, Singh K, Gupta A, Mathur M. Vitamin D levels and microvascular complications in type 2 diabetes. Indian J Endocrinol Metab 2014; 18(4): 537-41.
11. Bonakdaran S, Shoeibi N. Is there any correlation between vitamin D insufficiency and diabetic retinopathy? Int J Ophthalmol-Chi 2015; 8(2): 326-31.
12. Wilkinson CP, Ferris FR, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003; 110(9): 1677-82.
13. Margulis AV, Pladevall M, Riera-Guardia N, Varas-Lorenzo C, Hazell L, Berkman ND, et al. Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa Scale and the RTI item bank. Clin Epidemiol 2014; 6: 359-68.
14. Dai L, Sheng B, Chen T, Wu Q, Liu R, Cai C, et al. A deep learning system for predicting time to progression of diabetic retinopathy. Nat Med 2024; 30(2): 584-94.
15. Pushparani DS, Varalakshmi J, Roobini K, Hamshapriya P, Livitha A. Diabetic Retinopathy-A Review. Curr Diabetes Rev 2025; 21(7): 43-55.
16. Tohari AM, Alhasani RH, Biswas L, Patnaik SR, Reilly J, Zeng Z, et al. Vitamin D Attenuates Oxidative Damage and Inflammation in Retinal Pigment Epithelial Cells. Antioxidants-Basel 2019; 8(9):
17. Albert DM, Scheef EA, Wang S, Mehraein F, Darjatmoko SR, Sorenson CM, et al. Calcitriol is a potent inhibitor of retinal neovascularization. Invest Ophth Vis Sci 2007; 48(5): 2327-34.
18. Ren Z, Li W, Zhao Q, Ma L, Zhu J. The impact of 1,25-dihydroxy vitamin D3 on the expressions of vascular endothelial growth factor and transforming growth factor-beta(1) in the retinas of rats with diabetes. Diabetes Res Clin Pr 2012; 98(3): 474-80.
19. Azizieh F, Alyahya KO, Raghupathy R. Association between levels of vitamin D and inflammatory markers in healthy women. J Inflamm Res 2016; 9: 51-7.
20. Zhang J, Upala S, Sanguankeo A. Relationship between vitamin D deficiency and diabetic retinopathy: a meta-analysis. Can J Ophthalmol 2017; 52(2): 219-24.
21. Wallace AM, Gibson S, de la Hunty A, Lamberg-Allardt C, Ashwell M. Measurement of 25-hydroxyvitamin D in the clinical laboratory: current procedures, performance characteristics and limitations. Steroids 2010; 75(7): 477-88.
22. Hilger J, Friedel A, Herr R, Rausch T, Roos F, Wahl DA, et al. A systematic review of vitamin D status in populations worldwide. Brit J Nutr 2014; 111(1): 23-45.
23. von Hippel PT. The heterogeneity statistic I(2) can be biased in small meta-analyses. Bmc Med Res Methodol 2015; 15: 35.
Published
2025/09/22
Issue
Ahead of print
Section
Original paper

Copyright (c) 2025 Hongyu Wei, Hao Wang, Ke Diao, Xiaoxuan Wang, Hong Chen, Congying Wang, Minglian Zhang

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.